Specific chemotherapeutic agents, such as anthracyclines and oxaliplatin, induce also pro-immunogenic effects, by inducing the translocation on the plasma membrane of specific “eat me” signals, like the chaperon calreticulin, which triggers the tumor cell phagocytosis and the subsequent activation of antitumor CD8+ T-lymphocytes [3]. The gene discussed is CD8A; the disease is neoplasm.